SLC1A5 and breast carcinoma: In a pathophysiological environment previous findings demonstrated that heterofusion of breast cancer cells with endothelial cells involves endothelial-cell-associated ASCT2, which functions as a receptor for syncytin present on breast cancer cells [56].